| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ALLERGAN PLC | 475,000 | 129,110,000 | 7.27% | ||
| 2 | EDWARDS LIFESCIENCES CORP | 775,000 | 110,182,000 | 6.20% | ||
| 3 | STERICYCLE | 775,000 | 107,965,000 | 6.08% | ||
| 4 | BARD C R INC | 550,000 | 102,471,000 | 5.77% | ||
| 5 | ABBOTT LABS | 2,250,000 | 90,495,000 | 5.09% | ||
| 6 | PFIZER INC | 2,675,000 | 84,022,000 | 4.73% | ||
| 7 | LILLY ELI & CO | 1,000,000 | 83,690,000 | 4.71% | ||
| 8 | RITE AID CORP | 13,525,000 | 82,097,000 | 4.62% | ||
| 9 | MEDIVATION INC | 1,900,000 | 80,750,000 | 4.55% | ||
| 10 | AETNA INC NEW | 650,000 | 71,117,000 | 4.00% | ||
| 11 | ALEXION PHARMACEUTIC | 450,000 | 70,376,000 | 3.96% | ||
| 12 | VERTEX PHARMACEUT | 650,000 | 67,691,000 | 3.81% | ||
| 13 | AKORN INC | 2,325,000 | 66,274,000 | 3.73% | ||
| 14 | LABORATORY CORP AMER HLDGS | 550,000 | 59,659,000 | 3.36% | ||
| 15 | UNIVERSAL HLTH SVCS INC | 475,000 | 59,285,000 | 3.34% | ||
| 16 | CORINDUS VASCULAR ROBOTICS I COM | 19,981,655 | 53,911,000 | 3.03% | ||
| 17 | MCKESSON CORP | 275,000 | 50,883,000 | 2.86% | ||
| 18 | HCA HOLDINGS INC | 575,000 | 44,482,000 | 2.50% | ||
| 19 | BROOKDALE SR LIVING INC | 1,925,000 | 44,198,000 | 2.49% | ||
| 20 | AGILENT TECHNOLOGIES INC | 1,000,000 | 34,330,000 | 1.93% | Call | |
| 21 | PFIZER INC | 1,000,000 | 31,410,000 | 1.77% | Call | |
| 22 | TEAM HEALTH HOLDINGS INCORPORATED | 450,000 | 24,314,000 | 1.37% | ||
| 23 | ACADIA PHARMACEUTICALS INC COM | 678,700 | 22,445,000 | 1.26% | ||
| 24 | UNITED THERAPEUTICS | 170,400 | 22,363,000 | 1.26% | ||
| 25 | COLLEGIUM PHARMACEUTICAL INC COM | 950,000 | 21,005,000 | 1.18% | ||
| 26 | ALERE INC | 400,000 | 19,260,000 | 1.08% | ||
| 27 | SAGENT PHARMACEUTICALS INC | 1,250,000 | 19,163,000 | 1.08% | ||
| 28 | ADVISORY BRD CO COM | 338,252 | 15,404,000 | 0.87% | ||
| 29 | RELYPSA INC | 829,041 | 15,346,000 | 0.86% | ||
| 30 | Anacor Pharmaceuticals Inc | 125,000 | 14,714,000 | 0.83% | ||
| 31 | ARBUTUS BIOPHARMA | 2,150,000 | 13,094,000 | 0.74% | ||
| 32 | AGILENT TECHNOLOGIES INC | 325,500 | 11,174,000 | 0.63% | ||
| 33 | CEMPRA INC | 350,000 | 9,744,000 | 0.55% | ||
| 34 | SEASPINE HLDGS CORP COM | 500,000 | 8,100,000 | 0.46% | ||
| 35 | NEUROCRINE BIOSCIE COM USD0.001 | 150,000 | 5,969,000 | 0.34% | ||
| 36 | WELLTOWER INC | 72,750 | 4,927,000 | 0.28% | ||
| 37 | VENTAS INC | 87,020 | 4,878,000 | 0.27% | ||
| 38 | CONATUS PHARMACEUTICALS INC COM | 1,008,500 | 4,488,000 | 0.25% | ||
| 39 | CELYAD SA | 87,181 | 3,649,000 | 0.21% | ||
| 40 | ASSEMBLY BIOSCIENCES INC | 318,621 | 3,046,000 | 0.17% | ||
| 41 | NATERA INC | 255,000 | 2,767,000 | 0.16% | ||
| 42 | DEXCOM | 25,000 | 2,147,000 | 0.12% | ||
| 43 | TANDEM DIABETES CARE INC | 225,800 | 1,989,000 | 0.11% | ||
| 44 | CATALYST PHARMACEUTICALS INC | 385,500 | 1,157,000 | 0.07% | ||
| 45 | Orexigen Therapeutics, Inc. | 425,000 | 897,000 | 0.05% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001343781-15-000008, filed 2015.11.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
